Andrology and Urologic Health (AUH)
The mission of the U-M Division of Andrology and Urologic Health is to be the national leader in advancing prostate cancer evaluation and transgender medicine and understanding, treating, and curing benign diseases of the prostate and male sexual and reproductive systems, all while training the next generation of urologic leaders.
The Division of Andrology and Urologic Health is the leader, both within Michigan and across the nation, in treatment of benign prostatic hyperplasia, prostate cancer evaluation, treatment of Peyronie's disease, erectile dysfunction and infertility.
The Division consists of six urology faculty members, three primary care faculty, three joint faculty members and two full-time physicians assistants who offer the entire spectrum of male and benign urologic care. The Division serves as the reference center for men seeking the latest treatments for benign prostate enlargement or innovative procedures such as UroLift and Histotripsy (soundwave oblative technology). AUH was also the first to offer injections for Peyronie's disease along with other groundbreaking treatments for male sexual and reproductive concerns.